Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) Patients

Clinical trial NCT01020383 · COMPLETED

Trial details

NCT number: NCT01020383
Sponsor: Ablynx, a Sanofi company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Unstable Angina Non ST Segment Elevation Myocardial Infarction (NSTEMI)Stable Angina (Associated With High Risk PCI)

Start date: 2009-09-01
Primary completion: 2011-04-01
Enrollment: 364

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.